Lydia Meder

1.9k citations
21 papers · 783 indexed · h-index 13
Topics
Lung Cancer Treatments and Mutations (6 papers)Lung Cancer Research Studies (5 papers)RNA modifications and cancer (4 papers)

In The Last Decade

Lydia Meder

18 papers receiving 775 citations

Peers

Lydia Meder
Comparison fields: 5 of 72
  • Oncology 408
  • Molecular Biology 395
  • Pulmonary and Respiratory Medicine 311
  • Cancer Research 198
  • Epidemiology 121
Replace Francesca Simionato with:
Francesca Simionato Italy
Wenyi Zhao China
Toshio Fujino Japan
Su-Su Zheng China
Gloria Manzotti Italy
Naixin Liang China
Qunling Zhang China
Pinzhu Huang China
Prashanth Prithviraj Australia
Laura M. Rosenberg United States
Lydia Meder relative to Francesca Simionato Italy Francesca Simionato's profile →
Citations per field
00.5×6.1×
Francesca Simionato · 1×
Citations per year

Countries citing papers authored by Lydia Meder

Since Specialization
Citations

This map shows the geographic impact of Lydia Meder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Meder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Meder more than expected).

Fields of papers citing papers by Lydia Meder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Meder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Meder. The network helps show where Lydia Meder may publish in the future.

Co-authorship network of co-authors of Lydia Meder

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Meder. A scholar is included among the top collaborators of Lydia Meder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Meder. Lydia Meder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 5
4 14
5 11
6 12
7 3
8 42
9 22
10 18
11 31
12 27
13 44
14 1
15 141
16 8
17 164
18 24
19 15
20 201

About Lydia Meder

Lydia Meder is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 783 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (408 citations), Cancer Research (198 citations) and Pulmonary and Respiratory Medicine (311 citations). Lydia Meder has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lukas C. Heukamp, Mirjam Koker, Roman K. Thomas, Martin Peifer, Katharina König, Roland T. Ullrich, Reinhard Buettner, Florian Malchers, Jürgen Wolf and Johannes M. Heuckmann. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026